Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
10/2010
10/28/2010US20100272817 Compositions and Methods for Treating Atherosclerosis
10/28/2010US20100272815 Amorphous form of tapentadol hydrochloride
10/28/2010US20100272813 Nanoparticle-mediated treatment for inflammatory diseases
10/28/2010US20100272809 Microparticles comprising somatostatin analogues
10/28/2010US20100272802 Compositions comprising strontium and uses thereof in the treatment or prevention of gingivitis, periodontitis, periodontitis as a manifestation of systemic diseases, and necrotizing periodontal diseases
10/28/2010US20100272789 External medicine for treatment or prevention
10/28/2010US20100272787 Amethod of treating neurodegenerative diseases
10/28/2010US20100272762 Freeze-Dried Coated Molded Article
10/28/2010US20100272756 Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation
10/28/2010US20100272754 Botulinum toxin administration to treat various conditions
10/28/2010US20100272735 METHOD TO TREAT USING ANTAGONISTIC ANTI-hTNFSF13B HUMAN ANTIBODIES
10/28/2010US20100272733 Antibodies specific to pro-angiogenic isoforms of vascular endothelial growth factor (vegf)
10/28/2010US20100272731 Engineered anti-il-23p19 antibodies
10/28/2010US20100272730 Antigenic GM-CSF Peptides And Antibodies To GM-CSF
10/28/2010US20100272726 Assays, methods and means
10/28/2010US20100272718 Antibodies Against Human NKG2D and Uses Thereof
10/28/2010US20100272716 Antibodies to VLA-1
10/28/2010US20100272702 Methods and compositions for treating neuropathies
10/28/2010US20100272639 Polysaccharide nanoparticles
10/28/2010CA2759714A1 Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitors
10/28/2010CA2759713A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
10/28/2010CA2759706A1 Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitors
10/28/2010CA2759697A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
10/28/2010CA2759621A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
10/28/2010CA2759614A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
10/28/2010CA2759604A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
10/28/2010CA2759547A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
10/28/2010CA2759505A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
10/28/2010CA2759501A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
10/28/2010CA2759442A1 Galactooligosaccharide for use in prevention of intestinal inflammatory disorder
10/28/2010CA2759368A1 5-alkynyl-pyridines
10/28/2010CA2759127A1 A novel formulation of meloxicam
10/28/2010CA2758968A1 2,5-disubstituted arylsulfonamide ccr3 antagonists
10/28/2010CA2756876A1 A process for the preparation of frovatriptan and frovatriptan succinate and their synthetic intermediates
10/28/2010CA2748414A1 Inhibitors of bruton's tyrosine kinase
10/27/2010EP2243829A1 Improved humanized anti-human 9-integrin antibody
10/27/2010EP2243772A1 Novel P2X7R antagonists and their use
10/27/2010EP2243478A1 Pharmaceutical composition combining an antiarthritic agent and an interleukin-1 inhibiting agent, which can be used to control and treat osteoarthritis and related diseases
10/27/2010EP2243477A1 Paracetamol for parenteral application
10/27/2010EP2242753A1 Oxazolidine and thiazolidine selective subtype alpha 2 adrenergic agents and methods for use thereof
10/27/2010EP2242367A2 Rel inhibitors and methods of use thereof
10/27/2010EP2007735B1 2-substituted 4-benzylphthalazinone derivatives as histamine h1 and h3 antagonists
10/27/2010EP1907399B1 5,6-di-substituted oxadiazolopyrazines and thiadiazolopyrazines as cxc-chemokine receptor ligands
10/27/2010EP1539710B1 Heterocyclic derivatives
10/27/2010EP1432408B1 Pharmaceutical compositions comprising colloidal silicon dioxide
10/27/2010EP1218509B9 Fibroblast growth factor-like polypeptides
10/27/2010CN1918156B Isothiazole dioxides as CXC- and CC-chemokine receptor ligands
10/27/2010CN1826118B Multiparticulates
10/27/2010CN1678317B 1-amido-4-phenyl-4-benzyloxymethyl-piperidine derivatives and related compounds as neurokinin-1(NK-1) antagonists for the treatment of emesis, depression, anxiety and cough
10/27/2010CN1649568B Pharmaceutical compositions for the treatment of asthma
10/27/2010CN1585640B N-adamantylmethyl derivates and intermediates as pharmaceutical compositions and processes for their preparation
10/27/2010CN101874023A Alkylthio pyrimidines as CRTH2 antagonists
10/27/2010CN101870769A PEG (Polyethylene Glycol), mPEG (Methoxy Polyethylene Glycol) chemical modifier and method thereof for preparing water-soluble resveratrol prodrug
10/27/2010CN101870768A Polyethylene glycol derivatives of activated lactone compounds
10/27/2010CN101870734A Fusogenic polypeptide for inhibiting neovascularization and coding gene and application thereof
10/27/2010CN101869698A Liniment with combination of Chinese medicine and western medicine for fire treatment and preparation method thereof
10/27/2010CN101869697A Garden balsam stem-divaricate saposhnikovia root decoction for treating periarthritis of shoulder
10/27/2010CN101869696A Method for preparing plaster for treating rheumatic bone diseases
10/27/2010CN101869692A Curcumin self-microemulsion and preparation method thereof
10/27/2010CN101869676A Medicinal liquor for treating cold and dampness
10/27/2010CN101869675A Chinese medicinal composition granules for treating summer-heat damp cold and preparation method thereof
10/27/2010CN101869672A Moxibustion liquid and preparation process thereof
10/27/2010CN101869671A Paste for waist, leg, shoulder and neck
10/27/2010CN101869641A External medicinal liquor plaster for treating rheumatic diseases
10/27/2010CN101869637A Medicament for treating rheumatism arthritis and preparation method thereof
10/27/2010CN101869625A Chinese medicament for treating sciatica
10/27/2010CN101869624A External Chinese medicinal liquor for treating gout, acute coronary insufficiency, hypertension, chiral and pedal numbness and stremma
10/27/2010CN101869621A Composition with antimicrobial, immunity improving and anti-inflammatory effects
10/27/2010CN101869620A Quick-response medicated wine
10/27/2010CN101869613A Medicament for treating traumatic injury, sequela and hemiplegia caused by cerebral apoplexy and preparation method thereof
10/27/2010CN101869607A Spray for fulfilling functions of prevention and health care on uncomfortable joint caused by wind cold dampness and preparation method
10/27/2010CN101869605A Method for extracting and separating mulberry leaf flavone and alkaloid composite
10/27/2010CN101869602A Compound evening primrose and linseed oil fat emulsion intravenous fluid and preparation method
10/27/2010CN101869599A Compound walnut and perilla herb oil fat emulsion intravenous fluid and preparation method
10/27/2010CN101869598A Compound evening primrose and perilla herb oil fat emulsion intravenous fluid and preparation method
10/27/2010CN101869591A Method for producing alkannin by utilizing Arnebia euchroma(Royle)Johnst hairy root
10/27/2010CN101869584A Processing technique of tree sap fusion agent
10/27/2010CN101869565A Novel use of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine and its physiologically acceptable salts
10/27/2010CN101361786B Total-flavone extraction and purification and its monomer separation method from Lespedaza bedysaroides
10/27/2010CN101288728B Plaster for treating rheumatism, rheumatoid, a variety of hyperosteogenys
10/27/2010CN101279092B Applications of VEGF receptor fusion protein in preparation of medicament for curing diseases about angiogenesis
10/27/2010CN101229172B Solid dispersing agent of glycyrrhetinic acid 30-acylamide derivatives, preparing method and uses thereof
10/27/2010CN101102773B Aminopyrazine analogs for treating glaucoma and other RHO kinase-mediated diseases
10/26/2010US7820819 inhibitors of immunoglobulin E or G receptor signaling cascades; Syk kinase inhibitors; use as antiallergic, antiinflammatory agents
10/26/2010US7820814 Inhibitors of kinases
10/26/2010US7820792 isoform of the alpha 2 delta -4 subunit of a voltage gated calcium channel; useful to identify modulators of the channel subunit; for cancer and inflammation
10/26/2010US7820722 Comprises a multi-carbon backbone having an at least partially neutralized carboxy or sulfonic functional group and also one or more side chains that have one or more carbon atoms and, optionally, one or more functional groups.
10/26/2010US7820717 4-Chloro-2-phenylsulfanyl-phenyl)-4-isopropoxy-benzenesulfonamide; inflammatory bowl disease such as Crohn's disease or Colitis
10/26/2010US7820714 Increased selectivity for sialic acid binding Ig-like lectins (Siglec); improving immune response dependent on B-cells
10/26/2010US7820697 1-Oxo-2-(2,6-dioxopiperidin-3-yl)-4-methylisoindoline; treatment of cancers, rheumatoid arthritis, inflammatory bowel disease, muscular dystrophy, Crohn's disease and viral disease
10/26/2010US7820679 N-(-3-methoxy-5-methylpyrazin-2-yl)-2-(4-′1,3,4-oxadiazol-2-yl-phenyl)pyridine-3 sulphonamide as an anticancer agent
10/26/2010US7820669 2-(piperidin-4-yl)-4,5-dihydro-2H-pyridazin-3-one derivatives as PDE4 inhibitors
10/26/2010US7820644 Substituted porphyrins
10/26/2010US7820400 Tumor-associated marker
10/26/2010US7820178 VEGF isoforms and their use as anti-angiogenic, anti-vasodilatory, anti-permeability and anti-proliferative agents
10/26/2010US7820170 monoclonal antibody exhibit antagonist activity of the anti-CD40 antibody; antiproliferative agents; controlling cell differentiation; anticarcinogenic agents; Hodgkin's disease, leukemias
10/26/2010US7820161 Treatment of autoimmune diseases
10/26/2010CA2565813C Substituted methyl aryl or heteroaryl amide compounds
10/26/2010CA2543650C A crystalline form of the salt of 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide or the solvate of the salt and a process for preparing thesame
10/26/2010CA2487270C Antimicrobial compositions, products and methods employing same
1 ... 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 ... 1272